Diklazon desglicil

Diclazafone desglycyl is a chemical compound that can act as both a prodrug and a synthetic precursor for the benzodiazepine derivative delorazepam, the N-desmethyl derivative of the designer benzodiazepine diclazepam. It is inactive in vitro but has similar effects to delorazepam in vivo due to metabolic conversion to the active benzodiazepine form. It has been detected as a designer drug, first being identified in Denmark in September 2024.

Also known as: 2-amino-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]acetamide

Classification

No data available for this section yet.

Effects

No data available for this section yet.

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu